Deep learning shows promise for soft tissue sarcoma management

by KeAi Communications Co. How the DL-based AI in STSs WORK. Credit: Xu, R., et al Soft tissue sarcomas (STSs) represent a diverse group of tumors that pose significant diagnostic and therapeutic challenges. In a recent review published in the journal Meta-Radiology, a team of researchers from The Second Xiangya Hospital at Central South University in Changsha, China, explored the potential application of deep learning (DL) in revolutionizing the management of these complex tumors. “Deep learning has shown remarkable promise in various medical fields, and its application in STSs is Read More

Related posts:

  1. Can A.I. tell you if you have osteoporosis? Newly developed deep learning model shows promise
  2. Deep machine-learning speeds assessment of fruit fly heart aging and disease, a model for human disease
  3. Why the keto diet shows promise
  4. ‘Time cells’ in the brain are critical for complex learning, study shows
  5. Study shows mobile app therapy leads to significant improvement in fibromyalgia management
  6. Compound from olives shows promise for treating obesity and diabetes
  7. AI assistant shows great promise in cataract care pathway
  8. New tuberculosis vaccine candidate shows promise with post-translational modifications

Leave a Reply

Your email address will not be published. Required fields are marked *